ANW:FRA
Immuron Ltd
€0,020
0,00%
(0,00) 1G
9 Eki, 08:03:28 GMT+2 · EUR
search
Tüm semboller
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
insights_autoANW ile ilgili en önemli analizler oluşturuluyor...
Açık
€0,02
Yüksek
€0,02
Düşük
€0,02
Piy. değ.
10,33 Mn
Ort. hacim
627,00
İşlem Hacmi
0,00
52 haftalık en yüksek
€0,04
52 haftalık en düşük
€0,01
Çalışan sayısı
8
Açık
€0,02
Yüksek
€0,02
Düşük
€0,02
Piy. değ.
10,33 Mn
Ort. hacim
627,00
İşlem Hacmi
0,00
52 haftalık en yüksek
€0,04
52 haftalık en düşük
€0,01
Çalışan sayısı
8
Haberler
Web kaynaklarından ve haber iş ortaklarından
The Globe and Mail
·
28 dakika önce
Kaplan Fox Announces a Securities Class Action Filed Against AST SpaceMobile, Inc. (NASDAQ: ASTS) - Lead Plaintiff Deadline is November 13, 2026
Simply Wall Street
·
26 dakika önce
Top 3 AI Growth Stocks To Watch In October 2026
MarketBeat
·
19 dakika önce
The RMR Group (NASDAQ:RMR) Now Covered by Analysts at Maxim Group
Yahoo Finance
·
2 saat önce
History says midterms could hand the S&P 500 a year-end rally: Chart of the Day
Profil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Immuron Ltd hakkında
CEO-
Çalışan Sayısı8
Kuruluş Tarihi1994
Genel MerkezBlackburn North, Victoria, Avustralya
Sektör-
Web Sitesiimmuron.com.au